Meeting
2018 ASCO Annual Meeting
Integration of lymphocyte ratios (LRs) and circulating tumor cells (CTCs) characterization: The interplay between immunity and metastatic breast cancer (MBC).
Authors
Lorenzo Gerratana
Department of Medicine-Hematology and Oncology, Feinberg School of Medicine, Northwestern University; Department of Medicine (DAME), University of Udine; Department of Oncology, University Hospital of Udine, Udine, Italy
Lorenzo Gerratana , Michela Bulfoni , Debora Basile , Giacomo Pelizzari , Marta Bonotto , Antonio Paolo Beltrami , Qiang Zhang , Alessandro Marco Minisini , Carla Di Loreto , Gianpiero Fasola , Massimo Cristofanilli , Daniela Cesselli , Fabio Puglisi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 36, 2018 (suppl; abstr 12039)
DOI
10.1200/JCO.2018.36.15_suppl.12039
Abstract #
12039
Poster Bd #
152
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Correlation of circulating tumor cells (CTCs) with peripheral blood leukocytes to predict outcome in metastatic breast cancer (MBC).
First Author: Ugo De Giorgi
Poster
2023 ASCO Annual Meeting
Validation of a single-cell sequencing assay for the detection of circulating tumor cells in metastatic breast cancer.
First Author: David Bourdon
Poster
2022 ASCO Annual Meeting
ESR1 mutations in circulating tumor DNA (ctDNA) are associated with CTCs and increased hormone receptors in metastatic tumor tissues of patients with metastatic breast cancer (MBC).
First Author: Qiang Zhang
Poster
2021 ASCO Annual Meeting
Correlation between different levels of HER2 expression in circulating tumor cells (cHER2 ratio) and metastatic behavior in stageIVaggressive breast cancer.
First Author: Paolo D'Amico